1. Home
  2. ARCT vs ESQ Comparison

ARCT vs ESQ Comparison

Compare ARCT & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • ESQ
  • Stock Information
  • Founded
  • ARCT 2013
  • ESQ 2006
  • Country
  • ARCT United States
  • ESQ United States
  • Employees
  • ARCT N/A
  • ESQ N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • ARCT Health Care
  • ESQ Finance
  • Exchange
  • ARCT Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • ARCT 298.3M
  • ESQ 756.3M
  • IPO Year
  • ARCT N/A
  • ESQ 2017
  • Fundamental
  • Price
  • ARCT $13.78
  • ESQ $99.25
  • Analyst Decision
  • ARCT Strong Buy
  • ESQ Hold
  • Analyst Count
  • ARCT 8
  • ESQ 3
  • Target Price
  • ARCT $52.83
  • ESQ $95.00
  • AVG Volume (30 Days)
  • ARCT 484.1K
  • ESQ 124.2K
  • Earning Date
  • ARCT 08-04-2025
  • ESQ 07-24-2025
  • Dividend Yield
  • ARCT N/A
  • ESQ 0.71%
  • EPS Growth
  • ARCT N/A
  • ESQ 13.51
  • EPS
  • ARCT N/A
  • ESQ 5.27
  • Revenue
  • ARCT $143,680,000.00
  • ESQ $124,132,000.00
  • Revenue This Year
  • ARCT N/A
  • ESQ N/A
  • Revenue Next Year
  • ARCT $34.79
  • ESQ $10.72
  • P/E Ratio
  • ARCT N/A
  • ESQ $18.84
  • Revenue Growth
  • ARCT 15.38
  • ESQ 14.72
  • 52 Week Low
  • ARCT $8.04
  • ESQ $46.10
  • 52 Week High
  • ARCT $25.88
  • ESQ $99.75
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 57.25
  • ESQ 70.61
  • Support Level
  • ARCT $12.65
  • ESQ $93.57
  • Resistance Level
  • ARCT $14.09
  • ESQ $99.75
  • Average True Range (ATR)
  • ARCT 0.93
  • ESQ 3.03
  • MACD
  • ARCT 0.05
  • ESQ 0.65
  • Stochastic Oscillator
  • ARCT 60.04
  • ESQ 94.55

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: